Global Submucosal Injections Market By Type of Agent (Eleview and ORISE Gel, Succinylated Gelatin, Normal Saline, Hydroxypropyl Methylcellulose, Hydroxyethyl Starch, Hyaluronic Acid, Fibrinogen Mixture and Dextrose Water), By Application (Colorectal Cancer, Esophageal Cancer and Gastric Cancer), By End-User (Hospitals, Surgical Centers and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Table of Contents

• 1. Executive Summary
  • 1.1. Definition
  • 1.2. Market Snapshot
  • 1.3. Market Overview
  • 1.4. Segment Overview
  • 1.5. Regional Overview
  • 1.6. Competitive Landscape
  • 1.7. Taxonomy
  • 1.8. Industry Voices
• 2. Global Market Overview
  • 2.1. Global Market Insights and Industry Overview
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunities
    • 2.2.4. Key Submucosal Injections Market Trends
  • 2.3. Technology Landscape
  • 2.4. Regulatory Framework
  • 2.5. Sustainability and ESG (Environmental, Social, Governance)
  • 2.6. Opportunity Map Analysis
  • 2.7. Opportunity Orbits
  • 2.8. PESTLE Analysis
  • 2.9. PORTER’S Five Force Analysis
  • 2.10. Drivers & Restraints Impact Analysis
  • 2.11. Value Chain Analysis
    • 2.11.1. List of Raw Materials Suppliers
    • 2.11.2. List of Submucosal Injections Manufacturers
    • 2.11.3. List of Dealer/Distributors
  • 2.12. Regional Market Share and BPS Analysis
  • 2.13. Impact of Macro-economic Factors/Geopolitical Factors
• 3. Global Submucosal Injections Market Analysis and Forecast, By Segment, 2020-2034
  • • 3.1. Key Findings
    • 3.2. Global Submucosal Injections Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type of Agent, 2020-2034
    • 3.3. Global Submucosal Injections Market Attractiveness Analysis, By Type of Agent
    • 3.3.1. Eleview and Orise Gel
    • 3.3.1.1. Insights
    • 3.3.1.2. Key Takeaways
    • 3.3.2. Succinylated gelatin
    • 3.3.2.1. Insights
    • 3.3.2.2. Key Takeaways
    • 3.3.3. Normal saline
    • 3.3.3.1. Insights
    • 3.3.3.2. Key Takeaways
    • 3.3.4. Hydroxypropyl methylcellulose
    • 3.3.4.1. Insights
    • 3.3.4.2. Key Takeaways
    • 3.3.5. Hydroxyethyl starch
    • 3.3.5.1. Insights
    • 3.3.5.2. Key Takeaways
    • 3.3.6. Hyaluronic acid
    • 3.3.6.1. Insights
    • 3.3.6.2. Key Takeaways
    • 3.3.7. Fibrinogen mixture
    • 3.3.7.1. Insights
    • 3.3.7.2. Key Takeaways
    • 3.3.8. Dextrose water
    • 3.3.8.1. Insights
    • 3.3.8.2. Key Takeaways
    • 3.4. Global Submucosal Injections Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
    • 3.5. Global Submucosal Injections Market Attractiveness Analysis, By Application
    • 3.5.1. Colorectal cancer
    • 3.5.1.1. Insights
    • 3.5.1.2. Key Takeaways
    • 3.5.2. Esophageal cancer
    • 3.5.2.1. Insights
    • 3.5.2.2. Key Takeaways
    • 3.5.3. Gastric cancer
    • 3.5.3.1. Insights
    • 3.5.3.2. Key Takeaways
    • 3.6. Global Submucosal Injections Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
    • 3.7. Global Submucosal Injections Market Attractiveness Analysis, By End-user
    • 3.7.1. Hospitals
    • 3.7.1.1. Insights
    • 3.7.1.2. Key Takeaways
    • 3.7.2. Surgical centers
    • 3.7.2.1. Insights
    • 3.7.2.2. Key Takeaways
    • 3.7.3. Others
    • 3.7.3.1. Insights
    • 3.7.3.2. Key Takeaways
• 4. Global Submucosal Injections Market Analysis and Forecast, By Region, 2020-2034
  • • 4.1. Key Findings
    • 4.2. Global Submucosal Injections Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2020-2034
    • 4.2.1. North America
    • 4.2.1.1. Regional Insights
    • 4.2.2. Europe
    • 4.2.2.1. Regional Insights
    • 4.2.3. Asia Pacific
    • 4.2.3.1. Regional Insights
    • 4.2.4. Latin America
    • 4.2.4.1. Regional Insights
    • 4.2.5. Middle East & Africa
    • 4.2.5.1. Regional Insights
    • 4.3. Global Submucosal Injections Market Attractiveness Analysis, By Region
• 5. North America Submucosal Injections Market Analysis and Forecast, 2020-2034
  • • 5.1. Key Findings
    • 5.2. North America Submucosal Injections Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type of Agent, 2020-2034
    • 5.3. North America Submucosal Injections Market Attractiveness Analysis, By Type of Agent
    • 5.4. North America Submucosal Injections Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
    • 5.5. North America Submucosal Injections Market Attractiveness Analysis, By Application
    • 5.6. North America Submucosal Injections Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
    • 5.7. North America Submucosal Injections Market Attractiveness Analysis, By End-user
    • 5.8. North America Submucosal Injections Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
    • 5.9. North America Submucosal Injections Market Attractiveness Analysis, By Country
    • 5.9.1. The US
    • 5.9.2. Canada
• 6. Europe Submucosal Injections Market Analysis and Forecast, 2020-2034
  • • 6.1. Key Findings
    • 6.2. Europe Submucosal Injections Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type of Agent, 2020-2034
    • 6.3. Europe Submucosal Injections Market Attractiveness Analysis, By Type of Agent
    • 6.4. Europe Submucosal Injections Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
    • 6.5. Europe Submucosal Injections Market Attractiveness Analysis, By Application
    • 6.6. Europe Submucosal Injections Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
    • 6.7. Europe Submucosal Injections Market Attractiveness Analysis, By End-user
    • 6.8. Europe Submucosal Injections Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
    • 6.9. Europe Submucosal Injections Market Attractiveness Analysis, By Country
    • 6.9.1. Germany
    • 6.9.2. The UK
    • 6.9.3. France
    • 6.9.4. Spain
    • 6.9.5. Italy
    • 6.9.6. Russia
    • 6.9.7. Netherland
    • 6.9.8. Rest of Europe
• 7. Asia Pacific Submucosal Injections Market Analysis and Forecast, 2020-2034
  • • 7.1. Key Findings
    • 7.2. Asia Pacific Submucosal Injections Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type of Agent, 2020-2034
    • 7.3. Asia Pacific Submucosal Injections Market Attractiveness Analysis, By Type of Agent
    • 7.4. Asia Pacific Submucosal Injections Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
    • 7.5. Asia Pacific Submucosal Injections Market Attractiveness Analysis, By Application
    • 7.6. Asia Pacific Submucosal Injections Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
    • 7.7. Asia Pacific Submucosal Injections Market Attractiveness Analysis, By End-user
    • 7.8. Asia Pacific Submucosal Injections Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
    • 7.9. Asia Pacific Submucosal Injections Market Attractiveness Analysis, By Country
    • 7.9.1. China
    • 7.9.2. Japan
    • 7.9.3. South Korea
    • 7.9.4. India
    • 7.9.5. Australia
    • 7.9.6. New Zealand
    • 7.9.7. Singapore
    • 7.9.8. Thailand
    • 7.9.9. Vietnam
    • 7.9.10. Rest of Asia Pacific
• 8. Latin America Submucosal Injections Market Analysis and Forecast, 2020-2034
  • • 8.1. Key Findings
    • 8.2. Latin America Submucosal Injections Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type of Agent, 2020-2034
    • 8.3. Latin America Submucosal Injections Market Attractiveness Analysis, By Type of Agent
    • 8.4. Latin America Submucosal Injections Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
    • 8.5. Latin America Submucosal Injections Market Attractiveness Analysis, By Application
    • 8.6. Latin America Submucosal Injections Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
    • 8.7. Latin America Submucosal Injections Market Attractiveness Analysis, By End-user
    • 8.8. Latin America Submucosal Injections Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
    • 8.9. Latin America Submucosal Injections Market Attractiveness Analysis, By Country
    • 8.9.1. Brazil
    • 8.9.2. Mexico
    • 8.9.3. Rest of Latin America
• 9. Middle East & Africa Submucosal Injections Market Analysis and Forecast, 2020-2034
  • • 9.1. Key Findings
    • 9.2. Middle East & Africa Submucosal Injections Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type of Agent, 2020-2034
    • 9.3. Middle East & Africa Submucosal Injections Market Attractiveness Analysis, By Type of Agent
    • 9.4. Middle East & Africa Submucosal Injections Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
    • 9.5. Middle East & Africa Submucosal Injections Market Attractiveness Analysis, By Application
    • 9.6. Middle East & Africa Submucosal Injections Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
    • 9.7. Middle East & Africa Submucosal Injections Market Attractiveness Analysis, By End-user
    • 9.8. Middle East & Africa Submucosal Injections Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
    • 9.9. Middle East & Africa Submucosal Injections Market Attractiveness Analysis, By Country
    • 9.9.1. South Africa
    • 9.9.2. Saudi Arabia
    • 9.9.3. UAE
    • 9.9.4. Rest of Middle East & Africa
• 10. Competitive Landscape & Company Profiles
  • 10.1. Market Competition Scenario Analysis, By Company
  • 10.1.1. Key Takeaways
  • 10.2. Overview of Major Market Players
  • 10.3. Competitor Landscape
  • 10.4. Strategic Mapping
  • 10.5. Company Life Cycle Analysis
  • 10.6. Company Market Share Analysis
  • 10.7. Company Profiles
  • 10.7.1. GI Supply
  • 10.7.1.1. Company Details
  • 10.7.1.2. Business Overview
  • 10.7.1.3. Product Portfolio
  • 10.7.1.4. Financial Insights
  • 10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
  • 10.7.1.6. SWOT Analysis
  • 10.7.1.7. Geographic Footprint
  • 10.7.2. Cosmo Pharmaceuticals N.V.
  • 10.7.2.1. Company Details
  • 10.7.2.2. Business Overview
  • 10.7.2.3. Product Portfolio
  • 10.7.2.4. Financial Insights
  • 10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
  • 10.7.2.6. SWOT Analysis
  • 10.7.2.7. Geographic Footprint
  • 10.7.3. ERBE Elektromedizin GmbH
  • 10.7.3.1. Company Details
  • 10.7.3.2. Business Overview
  • 10.7.3.3. Product Portfolio
  • 10.7.3.4. Financial Insights
  • 10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
  • 10.7.3.6. SWOT Analysis
  • 10.7.3.7. Geographic Footprint
  • 10.7.4. Boston Scientific
  • 10.7.4.1. Company Details
  • 10.7.4.2. Business Overview
  • 10.7.4.3. Product Portfolio
  • 10.7.4.4. Financial Insights
  • 10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
  • 10.7.4.6. SWOT Analysis
  • 10.7.4.7. Geographic Footprint
  • 10.7.5. Olympus Corporation
  • 10.7.5.1. Company Details
  • 10.7.5.2. Business Overview
  • 10.7.5.3. Product Portfolio
  • 10.7.5.4. Financial Insights
  • 10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
  • 10.7.5.6. SWOT Analysis
  • 10.7.5.7. Geographic Footprint
  • 10.7.6. Taewoong Medical
  • 10.7.6.1. Company Details
  • 10.7.6.2. Business Overview
  • 10.7.6.3. Product Portfolio
  • 10.7.6.4. Financial Insights
  • 10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
  • 10.7.6.6. SWOT Analysis
  • 10.7.6.7. Geographic Footprint
  • 10.7.7. Endo-Flex GmbH
  • 10.7.7.1. Company Details
  • 10.7.7.2. Business Overview
  • 10.7.7.3. Product Portfolio
  • 10.7.7.4. Financial Insights
  • 10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
  • 10.7.7.6. SWOT Analysis
  • 10.7.7.7. Geographic Footprint
  • 10.7.8. Medtronic
  • 10.7.8.1. Company Details
  • 10.7.8.2. Business Overview
  • 10.7.8.3. Product Portfolio
  • 10.7.8.4. Financial Insights
  • 10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
  • 10.7.8.6. SWOT Analysis
  • 10.7.8.7. Geographic Footprint
  • 10.7.9. Seikagaku Corp
  • 10.7.9.1. Company Details
  • 10.7.9.2. Business Overview
  • 10.7.9.3. Product Portfolio
  • 10.7.9.4. Financial Insights
  • 10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
  • 10.7.9.6. SWOT Analysis
  • 10.7.9.7. Geographic Footprint
  • 10.7.10. Ovesco Endoscopy AG
  • 10.7.10.1. Company Details
  • 10.7.10.2. Business Overview
  • 10.7.10.3. Product Portfolio
  • 10.7.10.4. Financial Insights
  • 10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
  • 10.7.10.6. SWOT Analysis
  • 10.7.10.7. Geographic Footprint
• 11. Methodology and Data Source
  • 11.1. Methodology/Research Approach
  • 11.2. Market Size Estimation
  • 11.3. Market Breakdown and Data Triangulation
  • 11.4. Data Source
  • 11.5. Secondary Sources
  • 11.6. Primary Sources
  • 11.7. Appendix
  • 11.8. Disclaimer

List of Tables

• Table 1. Global Submucosal Injections Market Value (US$ Mn), By Type of Agent, 2020-2034
• Table 2. Global Submucosal Injections Market Value (US$ Mn), By Application, 2020-2034
• Table 3. Global Submucosal Injections Market Value (US$ Mn), By End-user, 2020-2034
• Table 4. Global Submucosal Injections Market Value (US$ Mn), By Region, 2020-2034
• Table 5. North America Submucosal Injections Market Value (US$ Mn), By Type of Agent, 2020-2034
• Table 6. North America Submucosal Injections Market Value (US$ Mn), By Application, 2020-2034
• Table 7. North America Submucosal Injections Market Value (US$ Mn), By End-user, 2020-2034
• Table 8. North America Submucosal Injections Market Value (US$ Mn), By Country, 2020-2034
• Table 9. The US Submucosal Injections Market Value (US$ Mn), By Type of Agent, 2020-2034
• Table 10. The US Submucosal Injections Market Value (US$ Mn), By Application, 2020-2034
• Table 11. The US Submucosal Injections Market Value (US$ Mn), By End-user, 2020-2034
• Table 12. Canada Submucosal Injections Market Value (US$ Mn), By Type of Agent, 2020-2034
• Table 13. Canada Submucosal Injections Market Value (US$ Mn), By Application, 2020-2034
• Table 14. Canada Submucosal Injections Market Value (US$ Mn), By End-user, 2020-2034
• Table 15. Europe Submucosal Injections Market Value (US$ Mn), By Type of Agent, 2020-2034
• Table 16. Europe Submucosal Injections Market Value (US$ Mn), By Application, 2020-2034
• Table 17. Europe Submucosal Injections Market Value (US$ Mn), By End-user, 2020-2034
• Table 18. Europe Submucosal Injections Market Value (US$ Mn), By Country, 2020-2034
• Table 19. Germany Submucosal Injections Market Value (US$ Mn), By Type of Agent, 2020-2034
• Table 20. Germany Submucosal Injections Market Value (US$ Mn), By Application, 2020-2034
• Table 21. Germany Submucosal Injections Market Value (US$ Mn), By End-user, 2020-2034
• Table 22. The UK Submucosal Injections Market Value (US$ Mn), By Type of Agent, 2020-2034
• Table 23. The UK Submucosal Injections Market Value (US$ Mn), By Application, 2020-2034
• Table 24. The UK Submucosal Injections Market Value (US$ Mn), By End-user, 2020-2034
• Table 25. France Submucosal Injections Market Value (US$ Mn), By Type of Agent, 2020-2034
• Table 26. France Submucosal Injections Market Value (US$ Mn), By Application, 2020-2034
• Table 27. France Submucosal Injections Market Value (US$ Mn), By End-user, 2020-2034
• Table 28. Spain Submucosal Injections Market Value (US$ Mn), By Type of Agent, 2020-2034
• Table 29. Spain Submucosal Injections Market Value (US$ Mn), By Application, 2020-2034
• Table 30. Spain Submucosal Injections Market Value (US$ Mn), By End-user, 2020-2034
• Table 31. Italy Submucosal Injections Market Value (US$ Mn), By Type of Agent, 2020-2034
• Table 32. Italy Submucosal Injections Market Value (US$ Mn), By Application, 2020-2034
• Table 33. Italy Submucosal Injections Market Value (US$ Mn), By End-user, 2020-2034
• Table 34. Russia Submucosal Injections Market Value (US$ Mn), By Type of Agent, 2020-2034
• Table 35. Russia Submucosal Injections Market Value (US$ Mn), By Application, 2020-2034
• Table 36. Russia Submucosal Injections Market Value (US$ Mn), By End-user, 2020-2034
• Table 37. Netherland Submucosal Injections Market Value (US$ Mn), By Type of Agent, 2020-2034
• Table 38. Netherland Submucosal Injections Market Value (US$ Mn), By Application, 2020-2034
• Table 39. Netherland Submucosal Injections Market Value (US$ Mn), By End-user, 2020-2034
• Table 40. Rest of Europe Submucosal Injections Market Value (US$ Mn), By Type of Agent, 2020-2034
• Table 41. Rest of Europe Submucosal Injections Market Value (US$ Mn), By Application, 2020-2034
• Table 42. Rest of Europe Submucosal Injections Market Value (US$ Mn), By End-user, 2020-2034
• Table 43. Asia Pacific Submucosal Injections Market Value (US$ Mn), By Type of Agent, 2020-2034
• Table 44. Asia Pacific Submucosal Injections Market Value (US$ Mn), By Application, 2020-2034
• Table 45. Asia Pacific Submucosal Injections Market Value (US$ Mn), By End-user, 2020-2034
• Table 46. Asia Pacific Submucosal Injections Market Value (US$ Mn), By Country, 2020-2034
• Table 47. China Submucosal Injections Market Value (US$ Mn), By Type of Agent, 2020-2034
• Table 48. China Submucosal Injections Market Value (US$ Mn), By Application, 2020-2034
• Table 49. China Submucosal Injections Market Value (US$ Mn), By End-user, 2020-2034
• Table 50. India Submucosal Injections Market Value (US$ Mn), By Type of Agent, 2020-2034
• Table 51. India Submucosal Injections Market Value (US$ Mn), By Application, 2020-2034
• Table 52. India Submucosal Injections Market Value (US$ Mn), By End-user, 2020-2034
• Table 53. Japan Submucosal Injections Market Value (US$ Mn), By Type of Agent, 2020-2034
• Table 54. Japan Submucosal Injections Market Value (US$ Mn), By Application, 2020-2034
• Table 55. Japan Submucosal Injections Market Value (US$ Mn), By End-user, 2020-2034
• Table 56. South Korea Submucosal Injections Market Value (US$ Mn), By Type of Agent, 2020-2034
• Table 57. South Korea Submucosal Injections Market Value (US$ Mn), By Application, 2020-2034
• Table 58. South Korea Submucosal Injections Market Value (US$ Mn), By End-user, 2020-2034
• Table 59. Australia Submucosal Injections Market Value (US$ Mn), By Type of Agent, 2020-2034
• Table 60. Australia Submucosal Injections Market Value (US$ Mn), By Application, 2020-2034
• Table 61. Australia Submucosal Injections Market Value (US$ Mn), By End-user, 2020-2034
• Table 62. New Zealand Submucosal Injections Market Value (US$ Mn), By Type of Agent, 2020-2034
• Table 63. New Zealand Submucosal Injections Market Value (US$ Mn), By Application, 2020-2034
• Table 64. New Zealand Submucosal Injections Market Value (US$ Mn), By End-user, 2020-2034
• Table 65. Singapore Submucosal Injections Market Value (US$ Mn), By Type of Agent, 2020-2034
• Table 66. Singapore Submucosal Injections Market Value (US$ Mn), By Application, 2020-2034
• Table 67. Singapore Submucosal Injections Market Value (US$ Mn), By End-user, 2020-2034
• Table 68. Thailand Submucosal Injections Market Value (US$ Mn), By Type of Agent, 2020-2034
• Table 69. Thailand Submucosal Injections Market Value (US$ Mn), By Application, 2020-2034
• Table 70. Thailand Submucosal Injections Market Value (US$ Mn), By End-user, 2020-2034
• Table 71. Vietnam Submucosal Injections Market Value (US$ Mn), By Type of Agent, 2020-2034
• Table 72. Vietnam Submucosal Injections Market Value (US$ Mn), By Application, 2020-2034
• Table 73. Vietnam Submucosal Injections Market Value (US$ Mn), By End-user, 2020-2034
• Table 74. Rest of Asia Pacific Submucosal Injections Market Value (US$ Mn), By Type of Agent, 2020-2034
• Table 75. Rest of Asia Pacific Submucosal Injections Market Value (US$ Mn), By Application, 2020-2034
• Table 76. Rest of Asia Pacific Submucosal Injections Market Value (US$ Mn), By End-user, 2020-2034
• Table 77. Latin America Submucosal Injections Market Value (US$ Mn), By Type of Agent, 2020-2034
• Table 78. Latin America Submucosal Injections Market Value (US$ Mn), By Application, 2020-2034
• Table 79. Latin America Submucosal Injections Market Value (US$ Mn), By End-user, 2020-2034
• Table 80. Latin America Submucosal Injections Market Value (US$ Mn), By Country, 2020-2034
• Table 81. Brazil Submucosal Injections Market Value (US$ Mn), By Type of Agent, 2020-2034
• Table 82. Brazil Submucosal Injections Market Value (US$ Mn), By Application, 2020-2034
• Table 83. Brazil Submucosal Injections Market Value (US$ Mn), By End-user, 2020-2034
• Table 84. Mexico Submucosal Injections Market Value (US$ Mn), By Type of Agent, 2020-2034
• Table 85. Mexico Submucosal Injections Market Value (US$ Mn), By Application, 2020-2034
• Table 86. Mexico Submucosal Injections Market Value (US$ Mn), By End-user, 2020-2034
• Table 87. Rest of Latin America Submucosal Injections Market Value (US$ Mn), By Type of Agent, 2020-2034
• Table 88. Rest of Latin America Submucosal Injections Market Value (US$ Mn), By Application, 2020-2034
• Table 89. Rest of Latin America Submucosal Injections Market Value (US$ Mn), By End-user, 2020-2034
• Table 90. Middle East & Africa Submucosal Injections Market Value (US$ Mn), By Type of Agent, 2020-2034
• Table 91. Middle East & Africa Submucosal Injections Market Value (US$ Mn), By Application, 2020-2034
• Table 92. Middle East & Africa Submucosal Injections Market Value (US$ Mn), By End-user, 2020-2034
• Table 93. Middle East & Africa Submucosal Injections Market Value (US$ Mn), By Country, 2020-2034
• Table 94. South Africa Submucosal Injections Market Value (US$ Mn), By Type of Agent, 2020-2034
• Table 95. South Africa Submucosal Injections Market Value (US$ Mn), By Application, 2020-2034
• Table 96. South Africa Submucosal Injections Market Value (US$ Mn), By End-user, 2020-2034
• Table 97. Saudi Arabia Submucosal Injections Market Value (US$ Mn), By Type of Agent, 2020-2034
• Table 98. Saudi Arabia Submucosal Injections Market Value (US$ Mn), By Application, 2020-2034
• Table 99. Saudi Arabia Submucosal Injections Market Value (US$ Mn), By End-user, 2020-2034
• Table 100. UAE Submucosal Injections Market Value (US$ Mn), By Type of Agent, 2020-2034
• Table 101. UAE Submucosal Injections Market Value (US$ Mn), By Application, 2020-2034
• Table 102. UAE Submucosal Injections Market Value (US$ Mn), By End-user, 2020-2034
• Table 103. Rest of Middle East & Africa Submucosal Injections Market Value (US$ Mn), By Type of Agent, 2020-2034
• Table 104. Rest of Middle East & Africa Submucosal Injections Market Value (US$ Mn), By Application, 2020-2034
• Table 105. Rest of Middle East & Africa Submucosal Injections Market Value (US$ Mn), By End-user, 2020-2034

List of Figures

• Figure 1. Global Submucosal Injections Market Snapshot: Market Value (US$ Mn), 2020-2034
• Figure 2. Opportunity Map
• Figure 3. Opportunity Orbit
• Figure 4. Regional Market Share and BPS Analysis in Submucosal Injections Market
• Figure 5. Global Submucosal Injections Market Analysis, By Type of Agent, 2020, 2024 and 2034
• Figure 6. Global Submucosal Injections Market Attractiveness Analysis, By Type of Agent
• Figure 7. Global Submucosal Injections Market Analysis, By Application, 2020, 2024 and 2034
• Figure 8. Global Submucosal Injections Market Attractiveness Analysis, By Application
• Figure 9. Global Submucosal Injections Market Analysis, By End-user, 2020, 2024 and 2034
• Figure 10. Global Submucosal Injections Market Attractiveness Analysis, By End-user
• Figure 11. Global Submucosal Injections Market Analysis, By Region, 2020, 2024 and 2034
• Figure 12. Global Submucosal Injections Market Attractiveness Analysis, By Region
• Figure 13. North America Submucosal Injections Market Analysis, By Type of Agent, 2020, 2024 and 2034
• Figure 14. North America Submucosal Injections Market Attractiveness Analysis, By Type of Agent
• Figure 15. North America Submucosal Injections Market (US$ Mn), by Eleview and Orise Gel, 2020-2034
• Figure 16. North America Submucosal Injections Market (US$ Mn), by Succinylated gelatin, 2020-2034
• Figure 17. North America Submucosal Injections Market (US$ Mn), by Normal saline, 2020-2034
• Figure 18. North America Submucosal Injections Market (US$ Mn), by Hydroxypropyl methylcellulose, 2020-2034
• Figure 19. North America Submucosal Injections Market (US$ Mn), by Hydroxyethyl starch, 2020-2034
• Figure 20. North America Submucosal Injections Market (US$ Mn), by Hyaluronic acid, 2020-2034
• Figure 21. North America Submucosal Injections Market (US$ Mn), by Fibrinogen mixture, 2020-2034
• Figure 22. North America Submucosal Injections Market (US$ Mn), by Dextrose water, 2020-2034
• Figure 23. North America Submucosal Injections Market Analysis, By Application, 2020, 2024 and 2034
• Figure 24. North America Submucosal Injections Market Attractiveness Analysis, By Application
• Figure 25. North America Submucosal Injections Market (US$ Mn), by Colorectal cancer, 2020-2034
• Figure 26. North America Submucosal Injections Market (US$ Mn), by Esophageal cancer, 2020-2034
• Figure 27. North America Submucosal Injections Market (US$ Mn), by Gastric cancer, 2020-2034
• Figure 28. North America Submucosal Injections Market Analysis, By End-user, 2020, 2024 and 2034
• Figure 29. North America Submucosal Injections Market Attractiveness Analysis, By End-user
• Figure 30. North America Submucosal Injections Market (US$ Mn), by Hospitals, 2020-2034
• Figure 31. North America Submucosal Injections Market (US$ Mn), by Surgical centers, 2020-2034
• Figure 32. North America Submucosal Injections Market (US$ Mn), by Others, 2020-2034
• Figure 33. North America Submucosal Injections Market Analysis, By Country, 2020, 2024 and 2034
• Figure 34. North America Submucosal Injections Market Attractiveness Analysis, By Country
• Figure 35. Europe Submucosal Injections Market Analysis, By Type of Agent, 2020, 2024 and 2034
• Figure 36. Europe Submucosal Injections Market Attractiveness Analysis, By Type of Agent
• Figure 37. Europe Submucosal Injections Market (US$ Mn), by Eleview and Orise Gel, 2020-2034
• Figure 38. Europe Submucosal Injections Market (US$ Mn), by Succinylated gelatin, 2020-2034
• Figure 39. Europe Submucosal Injections Market (US$ Mn), by Normal saline, 2020-2034
• Figure 40. Europe Submucosal Injections Market (US$ Mn), by Hydroxypropyl methylcellulose, 2020-2034
• Figure 41. Europe Submucosal Injections Market (US$ Mn), by Hydroxyethyl starch, 2020-2034
• Figure 42. Europe Submucosal Injections Market (US$ Mn), by Hyaluronic acid, 2020-2034
• Figure 43. Europe Submucosal Injections Market (US$ Mn), by Fibrinogen mixture, 2020-2034
• Figure 44. Europe Submucosal Injections Market (US$ Mn), by Dextrose water, 2020-2034
• Figure 45. Europe Submucosal Injections Market Analysis, By Application, 2020, 2024 and 2034
• Figure 46. Europe Submucosal Injections Market Attractiveness Analysis, By Application
• Figure 47. Europe Submucosal Injections Market (US$ Mn), by Colorectal cancer, 2020-2034
• Figure 48. Europe Submucosal Injections Market (US$ Mn), by Esophageal cancer, 2020-2034
• Figure 49. Europe Submucosal Injections Market (US$ Mn), by Gastric cancer, 2020-2034
• Figure 50. Europe Submucosal Injections Market Analysis, By End-user, 2020, 2024 and 2034
• Figure 51. Europe Submucosal Injections Market Attractiveness Analysis, By End-user
• Figure 52. Europe Submucosal Injections Market (US$ Mn), by Hospitals, 2020-2034
• Figure 53. Europe Submucosal Injections Market (US$ Mn), by Surgical centers, 2020-2034
• Figure 54. Europe Submucosal Injections Market (US$ Mn), by Others, 2020-2034
• Figure 55. Europe Submucosal Injections Market Analysis, By Country, 2020, 2024 and 2034
• Figure 56. Europe Submucosal Injections Market Attractiveness Analysis, By Country
• Figure 57. Asia Pacific Submucosal Injections Market Analysis, By Type of Agent, 2020, 2024 and 2034
• Figure 58. Asia Pacific Submucosal Injections Market Attractiveness Analysis, By Type of Agent
• Figure 59. Asia Pacific Submucosal Injections Market (US$ Mn), by Eleview and Orise Gel, 2020-2034
• Figure 60. Asia Pacific Submucosal Injections Market (US$ Mn), by Succinylated gelatin, 2020-2034
• Figure 61. Asia Pacific Submucosal Injections Market (US$ Mn), by Normal saline, 2020-2034
• Figure 62. Asia Pacific Submucosal Injections Market (US$ Mn), by Hydroxypropyl methylcellulose, 2020-2034
• Figure 63. Asia Pacific Submucosal Injections Market (US$ Mn), by Hydroxyethyl starch, 2020-2034
• Figure 64. Asia Pacific Submucosal Injections Market (US$ Mn), by Hyaluronic acid, 2020-2034
• Figure 65. Asia Pacific Submucosal Injections Market (US$ Mn), by Fibrinogen mixture, 2020-2034
• Figure 66. Asia Pacific Submucosal Injections Market (US$ Mn), by Dextrose water, 2020-2034
• Figure 67. Asia Pacific Submucosal Injections Market Analysis, By Application, 2020, 2024 and 2034
• Figure 68. Asia Pacific Submucosal Injections Market Attractiveness Analysis, By Application
• Figure 69. Asia Pacific Submucosal Injections Market (US$ Mn), by Colorectal cancer, 2020-2034
• Figure 70. Asia Pacific Submucosal Injections Market (US$ Mn), by Esophageal cancer, 2020-2034
• Figure 71. Asia Pacific Submucosal Injections Market (US$ Mn), by Gastric cancer, 2020-2034
• Figure 72. Asia Pacific Submucosal Injections Market Analysis, By End-user, 2020, 2024 and 2034
• Figure 73. Asia Pacific Submucosal Injections Market Attractiveness Analysis, By End-user
• Figure 74. Asia Pacific Submucosal Injections Market (US$ Mn), by Hospitals, 2020-2034
• Figure 75. Asia Pacific Submucosal Injections Market (US$ Mn), by Surgical centers, 2020-2034
• Figure 76. Asia Pacific Submucosal Injections Market (US$ Mn), by Others, 2020-2034
• Figure 77. Asia Pacific Submucosal Injections Market Analysis, By Country, 2020, 2024 and 2034
• Figure 78. Asia Pacific Submucosal Injections Market Attractiveness Analysis, By Country
• Figure 79. Latin America Submucosal Injections Market Analysis, By Type of Agent, 2020, 2024 and 2034
• Figure 80. Latin America Submucosal Injections Market Attractiveness Analysis, By Type of Agent
• Figure 81. Latin America Submucosal Injections Market (US$ Mn), by Eleview and Orise Gel, 2020-2034
• Figure 82. Latin America Submucosal Injections Market (US$ Mn), by Succinylated gelatin, 2020-2034
• Figure 83. Latin America Submucosal Injections Market (US$ Mn), by Normal saline, 2020-2034
• Figure 84. Latin America Submucosal Injections Market (US$ Mn), by Hydroxypropyl methylcellulose, 2020-2034
• Figure 85. Latin America Submucosal Injections Market (US$ Mn), by Hydroxyethyl starch, 2020-2034
• Figure 86. Latin America Submucosal Injections Market (US$ Mn), by Hyaluronic acid, 2020-2034
• Figure 87. Latin America Submucosal Injections Market (US$ Mn), by Fibrinogen mixture, 2020-2034
• Figure 88. Latin America Submucosal Injections Market (US$ Mn), by Dextrose water, 2020-2034
• Figure 89. Latin America Submucosal Injections Market Analysis, By Application, 2020, 2024 and 2034
• Figure 90. Latin America Submucosal Injections Market Attractiveness Analysis, By Application
• Figure 91. Latin America Submucosal Injections Market (US$ Mn), by Colorectal cancer, 2020-2034
• Figure 92. Latin America Submucosal Injections Market (US$ Mn), by Esophageal cancer, 2020-2034
• Figure 93. Latin America Submucosal Injections Market (US$ Mn), by Gastric cancer, 2020-2034
• Figure 94. Latin America Submucosal Injections Market Analysis, By End-user, 2020, 2024 and 2034
• Figure 95. Latin America Submucosal Injections Market Attractiveness Analysis, By End-user
• Figure 96. Latin America Submucosal Injections Market (US$ Mn), by Hospitals, 2020-2034
• Figure 97. Latin America Submucosal Injections Market (US$ Mn), by Surgical centers, 2020-2034
• Figure 98. Latin America Submucosal Injections Market (US$ Mn), by Others, 2020-2034
• Figure 99. Latin America Submucosal Injections Market Analysis, By Country, 2020, 2024 and 2034
• Figure 100. Latin America Submucosal Injections Market Attractiveness Analysis, By Country
• Figure 101. Middle East & Africa Submucosal Injections Market Analysis, By Type of Agent, 2020, 2024 and 2034
• Figure 102. Middle East & Africa Submucosal Injections Market Attractiveness Analysis, By Type of Agent
• Figure 103. Middle East & Africa Submucosal Injections Market (US$ Mn), by Eleview and Orise Gel, 2020-2034
• Figure 104. Middle East & Africa Submucosal Injections Market (US$ Mn), by Succinylated gelatin, 2020-2034
• Figure 105. Middle East & Africa Submucosal Injections Market (US$ Mn), by Normal saline, 2020-2034
• Figure 106. Middle East & Africa Submucosal Injections Market (US$ Mn), by Hydroxypropyl methylcellulose, 2020-2034
• Figure 107. Middle East & Africa Submucosal Injections Market (US$ Mn), by Hydroxyethyl starch, 2020-2034
• Figure 108. Middle East & Africa Submucosal Injections Market (US$ Mn), by Hyaluronic acid, 2020-2034
• Figure 109. Middle East & Africa Submucosal Injections Market (US$ Mn), by Fibrinogen mixture, 2020-2034
• Figure 110. Middle East & Africa Submucosal Injections Market (US$ Mn), by Dextrose water, 2020-2034
• Figure 111. Middle East & Africa Submucosal Injections Market Analysis, By Application, 2020, 2024 and 2034
• Figure 112. Middle East & Africa Submucosal Injections Market Attractiveness Analysis, By Application
• Figure 113. Middle East & Africa Submucosal Injections Market (US$ Mn), by Colorectal cancer, 2020-2034
• Figure 114. Middle East & Africa Submucosal Injections Market (US$ Mn), by Esophageal cancer, 2020-2034
• Figure 115. Middle East & Africa Submucosal Injections Market (US$ Mn), by Gastric cancer, 2020-2034
• Figure 116. Middle East & Africa Submucosal Injections Market Analysis, By End-user, 2020, 2024 and 2034
• Figure 117. Middle East & Africa Submucosal Injections Market Attractiveness Analysis, By End-user
• Figure 118. Middle East & Africa Submucosal Injections Market (US$ Mn), by Hospitals, 2020-2034
• Figure 119. Middle East & Africa Submucosal Injections Market (US$ Mn), by Surgical centers, 2020-2034
• Figure 120. Middle East & Africa Submucosal Injections Market (US$ Mn), by Others, 2020-2034
• Figure 121. Middle East & Africa Submucosal Injections Market Analysis, By Country, 2020, 2024 and 2034
• Figure 122. Middle East & Africa Submucosal Injections Market Attractiveness Analysis, By Country